H3D Foundation
The H3D Foundation supports drug innovation and science in Africa through initiatives to strengthen capacity, collaboration, and advocacy for African researchers and research centers. IFPMA and member companies partner with H3D Foundation to promote health innovation in Africa.
Overview
Launched in 2019, the H3D Foundation’s mission is to create capacity for building and retaining skilled African scientists within pharmaceutical research and development (R&D) on the continent.
The Foundation complements initiatives spearheaded by the Holistic Drug Discovery and Development (H3D) Centre of the University of Cape Town, acting as a convening platform to bring together credible voices in drug R&D, expand the Centre’s capacity building programs and outreach, develop new initiatives to fill skills gaps for laboratory and clinical activities, and strengthen innovation and access to drugs in the region.
The H3D Foundation uplifts African researchers and research centers through capacity strengthening initiatives, network and connection building, and fundraising.
How we support the H3D Foundation
Capacity strengthening
Scientific mobility, hosting drug discovery workshops and training, and mentorship to equip researchers with scientific skills, writing for publications and grant applications, and project management.
Network and connection building
Expanding existing partnerships between H3D and the innovative pharmaceutical industry to benefit African drug discovery scientists early and mid-career, and bringing together stakeholders from the public and private sectors, civil society, religious leaders, and community mobilizers to bridge the gaps that exist between science and the public and remove barriers to success in R&D.
Fundraising
Improving financial capacity to invest in R&D infrastructure, scientific events, and mentorship programs.
Related news and resources
See allForum unites key stakeholders to discuss Ghana’s health economy
Philip Tagboto, co-chair of the IFPMA Africa Engagement Committee, shares reflections from a multistakeholder forum organized by AREPI and IFPMA uniting various stakeholders from Ghana’s healthcare and pharmaceutical sectors.
Read more
AMATA statement on the Framework for strengthening local production of medicines, vaccines, and other health technologies in the WHO African Region 2025-2035
On 29 August at the 74th WHO Africa Regional Committee Meeting in Brazzaville, Republic of Congo, the African Medicines Agency Treaty Alliance delivered a statement on Agenda item 10: Framework for strengthening local production of medicines, vaccines, and other health technologies in the WHO African Region 2025-2035.
Read moreIFPMA statement on the Framework for strengthening local production of medicines, vaccines, and other health techonologies in the WHO African Region 2025-2035
On 28 August at the 74th WHO Africa Regional Committee Meeting in Brazzaville, Republic of Congo, IFPMA submitted a statement on Agenda item 10: Framework for strengthening local production of medicines, vaccines, and other health technologies in the WHO African Region 2025-2035.
Read moreEngage with the Foundation
The H3D Foundation is unlocking the potential for sustainable drug discovery and development in Africa. Read more
Other partnerships and alliances
See all
The International Council for Harmonisation (ICH)
As a Standing Observer of ICH, IFPMA along with other ICH Members and Observers, has an important role in promoting global convergence toward ICH regulatory standards and their harmonized interpretation.
INTREPID Alliance
INTREPID Alliance exists to accelerate the development of new treatments for emerging viral pandemic agents through coordinated early science and R&D, policy and advocacy and stakeholder engagement. INTREPID Alliance members collectively bring expertise in drug discovery, antiviral R&D and medicine manufacturing.
Navigating Innovation & Research Opportunities (NIRO)
Helping actors in research and innovation identify opportunities within and beyond the European Union